John Papadopoulos

787 total citations
20 papers, 373 citations indexed

About

John Papadopoulos is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, John Papadopoulos has authored 20 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Urology. Recurrent topics in John Papadopoulos's work include Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Urological Disorders and Treatments (5 papers). John Papadopoulos is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Urological Disorders and Treatments (5 papers). John Papadopoulos collaborates with scholars based in United States, Australia and South Korea. John Papadopoulos's co-authors include Robert R. Langley, Isaiah J. Fidler, Seung Wook Kim, Dominic Fan, Marva Maya, Fahao Zhang, Sun‐Jin Kim, Jang‐Seong Kim, Surena F. Matin and Christopher G. Wood and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and American Journal Of Pathology.

In The Last Decade

John Papadopoulos

18 papers receiving 369 citations

Peers

John Papadopoulos
Tomoyuki Shimabukuro Japan
Samuel Huang United States
Shinya Maita Japan
Angel Yordanov Bulgaria
Tomohiro Taki Japan
Györgyike Soós Hungary
Shinya Munakata Japan
Maxime Fastrez Belgium
Małgorzata Walentowicz‐Sadlecka Poland
Ece Esin Türkiye
Tomoyuki Shimabukuro Japan
John Papadopoulos
Citations per year, relative to John Papadopoulos John Papadopoulos (= 1×) peers Tomoyuki Shimabukuro

Countries citing papers authored by John Papadopoulos

Since Specialization
Citations

This map shows the geographic impact of John Papadopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Papadopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Papadopoulos more than expected).

Fields of papers citing papers by John Papadopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Papadopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Papadopoulos. The network helps show where John Papadopoulos may publish in the future.

Co-authorship network of co-authors of John Papadopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of John Papadopoulos. A scholar is included among the top collaborators of John Papadopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Papadopoulos. John Papadopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pettaway, Curtis A., Louis L. Pisters, John W. Davis, et al.. (2025). Grade Group 1 Core Volume at Time of Biopsy Is Not Associated With Rate of Adverse Pathology at Radical Prostatectomy. JU Open Plus. 3(9).
2.
Pieretti, Alberto, Graciela M. Nogueras‐González, John Papadopoulos, et al.. (2024). Robotic or open superficial inguinal lymph node dissection as staging procedures for clinically node negative high risk penile cancer. Urologic Oncology Seminars and Original Investigations. 42(4). 120.e1–120.e9. 4 indexed citations
3.
Davis, John W., Amado J. Zurita, Xuemei Wang, et al.. (2021). Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer. European Journal of Cancer. 157. 259–267. 12 indexed citations
4.
Kokorovic, Andrea, Wei Qiao, Mehrad Adibi, et al.. (2021). Oncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma: The University of Texas M.D. Anderson Cancer Center Experience. Urologic Oncology Seminars and Original Investigations. 39(5). 302.e19–302.e27. 7 indexed citations
5.
6.
Efstathiou, Eleni, Sijin Wen, Anh Hoang, et al.. (2020). Neoadjuvant apalutamide (APA) plus leuprolide (LHRHa) with or without abiraterone (AA) in localized high-risk prostate cancer (LHRPC).. Journal of Clinical Oncology. 38(15_suppl). 5504–5504. 11 indexed citations
7.
Zurita, Amado J., Rebecca S. Tidwell, Patricia Troncoso, et al.. (2019). Randomized phase II trial of presurgical androgen deprivation therapy (ADT) with or without axitinib in prostate cancer (PCa) presenting with lymph node (LN) metastasis.. Journal of Clinical Oncology. 37(15_suppl). 5078–5078.
8.
Balasubramanian, Adithya, Michael Metcalfe, Lianchun Xiao, et al.. (2018). Salvage topical therapy for upper tract urothelial carcinoma. World Journal of Urology. 36(12). 2027–2034. 9 indexed citations
9.
10.
Balasubramanian, Adithya, Michael Metcalfe, Lianchun Xiao, et al.. (2017). MP78-02 RESULTS OF SECOND LINE TOPICAL THERAPY FOR UPPER TRACT UROTHELIAL CARCINOMA (UTUC). The Journal of Urology. 197(4S). 1 indexed citations
11.
Metcalfe, Michael, Lianchun Xiao, John Papadopoulos, et al.. (2017). Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes. Journal of Endourology. 31(9). 946–953. 35 indexed citations
12.
13.
Katz, Matthew H. G., Rebecca Slack, Morgan L. Bruno, et al.. (2016). Outpatient virtual clinical encounters after complex surgery for cancer: a prospective pilot study of “TeleDischarge”. Journal of Surgical Research. 202(1). 196–203. 25 indexed citations
14.
Davis, John W., John F. Ward, Curtis A. Pettaway, et al.. (2015). Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable‐risk prostate cancer undergoing active surveillance. British Journal of Urology. 118(1). 68–76. 27 indexed citations
15.
Lee, Ho-Jeong, John Papadopoulos, Seung Wook Kim, et al.. (2012). Targeted Antivascular Therapy with the Apolipoprotein(a) Kringle V, rhLK8, Inhibits the Growth and Metastasis of Human Prostate Cancer in an Orthotopic Nude Mouse Model. Neoplasia. 14(4). 335–343. 11 indexed citations
16.
Kim, Seung Wook, John Papadopoulos, Hyun Jin Choi, et al.. (2011). Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse. International Immunopharmacology. 11(7). 862–872. 44 indexed citations
17.
Papageorgiou, Irène, et al.. (2010). Always think about omental torsion when the appendix looks normal. American Journal of Case Reports. 11. 138–141. 2 indexed citations
18.
Kim, Sun‐Jin, Jang‐Seong Kim, John Papadopoulos, et al.. (2009). Circulating Monocytes Expressing CD31. American Journal Of Pathology. 174(5). 1972–1980. 118 indexed citations
19.
Mathew, Paul, Louis L. Pisters, Christopher G. Wood, et al.. (2008). Neoadjuvant Platelet Derived Growth Factor Receptor Inhibitor Therapy Combined With Docetaxel and Androgen Ablation for High Risk Localized Prostate Cancer. The Journal of Urology. 181(1). 81–87. 30 indexed citations
20.
Shaw, Aubie, John Papadopoulos, Curtis D. Johnson, & Wade Bushman. (2006). Isolation and characterization of an immortalized mouse urogenital sinus mesenchyme cell line. The Prostate. 66(13). 1347–1358. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoyuki Shimabukuro Breakdown of academic impact, for papers by Samuel Huang Breakdown of academic impact, for papers by Shinya Maita Breakdown of academic impact, for papers by Angel Yordanov Breakdown of academic impact, for papers by Tomohiro Taki Breakdown of academic impact, for papers by Györgyike Soós Breakdown of academic impact, for papers by Shinya Munakata Breakdown of academic impact, for papers by Maxime Fastrez Breakdown of academic impact, for papers by Małgorzata Walentowicz‐Sadlecka Breakdown of academic impact, for papers by Ece Esin
Rankless by CCL
2026